Results 71 to 80 of about 927,140 (352)

Editor's Choice – Outcomes of Surgery for Patients with Peripheral Arterial Disease During the COVID-19 Pandemic in the United Kingdom: A Population Based Study [PDF]

, 2023
Panagiota Birmpili, Qiuju Li, Amundeep S. Johal, Sam Waton, Eleanor Atkins, Jonathan R. Boyle, Ian Chetter, Robin Williams, Arun Pherwani, David Cromwell   +9 more
openalex   +1 more source

Association between arterial stiffness and atherosclerosis: the Rotterdam Study [PDF]

, 2001
BACKGROUND AND PURPOSE: Studies of the association between arterial stiffness and atherosclerosis are contradictory. We studied stiffness of the aorta and the common carotid artery in relation to several indicators of atherosclerosis ...
Asmar, R. (Roland), Bots, M.L. (Michiel), Grobbee, D.E. (Diederick), Hoeks, A.P.G., Hofman, A. (Albert), Kuip, D.A.M. (Deirdre) van der, Popele, N.M-L. (Nicole) van, Reneman, R.S., Topouchian, J., Witteman, J.C.M. (Jacqueline)   +9 more
core   +1 more source

Secondhand smoke exposure and risk of incident peripheral arterial disease and mortality: a Scotland-wide retrospective cohort study of 4045 non-smokers with cotinine measurement [PDF]

, 2018
Background: Active smoking is an important risk factor for all-cause mortality and peripheral arterial disease (PAD). In contrast, published studies on the associations with secondhand smoke (SHS) are limited.
Lu, Liya, Mackay, Daniel F., Pell, Jill P.   +2 more
core   +1 more source

LOXHD1 and RHOB Expression by Monocytes Predicts Progressive Systemic Sclerosis associated Interstitial Lung Disease

Arthritis Care &Research, Accepted Article.
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla, Robert Lafyatis, Kevin F Gibson, Christina Morse, Eleanor Valenzi, Xiaoping Chen, Xiaoyun Li, Yanwu Zhao, Yongseok Park, Dana Ascherman, Jonathan Minden, Robyn Domsic, Yingze Zhang, Daniel J Kass   +13 more
wiley   +1 more source

Endothelial dysfunction in patients with Buerger disease

Vascular Health and Risk Management, 2017
Kimihiro Igari, Toshifumi Kudo, Takahiro Toyofuku, Yoshinori Inoue Division of Vascular and Endovascular Surgery, Department of Surgery, Tokyo Medical and Dental University, Tokyo, Japan Abstract: We evaluated the endothelial function of patients with ...
Igari K, Kudo T, Toyofuku T, Inoue Y
doaj  

Interventional Treatment Options for the Prevention of Amputation in Patients With Lower Extremity Wounds From Peripheral Arterial Disease [PDF]

Texas Heart Institute Journal
Background Peripheral arterial disease and related lower extremity wounds are prominent causes of amputation. Revascularization may reduce amputation rates or the amputation margin more distally in patients with peripheral arterial disease who have ...
Akin Torun, MD, Ulas Bildirici, MD
doaj   +1 more source

Predictors of walking capacity in peripheral arterial disease patients [PDF]

, 2013
OBJECTIVE: To estimate walking capacity in intermittent claudication patients through a prediction model based on clinical characteristics and the walking impairment questionnaire. METHODS: The sample included 133 intermittent claudication patients of
Chehuen, MR, Cucato, Gabriel, Farah, BQ, Forjaz, CL, Gobbo, LA, Ritti- Dias, RM, Souza-Barbosa, JP, Wolosker, N   +7 more
core   +2 more sources

Perceptions About Asymptomatic Hyperuricemia and Views About Urate‐Lowering Therapy in People With Asymptomatic Hyperuricemia

Arthritis Care &Research, EarlyView.
Objective Asymptomatic hyperuricemia is a precursor of gout and is also associated with cardiovascular disease and chronic kidney disease. The aim of this study was to understand perceptions about asymptomatic hyperuricemia and views about urate‐lowering therapy in people with asymptomatic hyperuricemia. Methods Participants in a multinational study of
Nicola Dalbeth, Sarah Stewart, Gregory D. Gamble, Borislav Mihov, Lisa K. Stamp, Janine Haslett, William J. Taylor, Tony R. Merriman, Adwoa Dansoa Tabi‐Amponsah, Anne Horne, Tuhina Neogi, Tristan Pascart, Mariano Andrés, Maria‐Luisa Peral‐Garrido, Eleonora Norkuviene, Janitzia Vazquez‐Mellado, Till Uhlig, Mingshu Sun, Changgui Li, Keith J. Petrie   +19 more
wiley   +1 more source

The incidence and predictors of peripheral arterial disease among type 2 diabetes mellitus patients at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia, 2023: A retrospective follow-up study.

PLoS ONE
BackgroundPeripheral arterial disease is a blockage or narrowing of arteries transporting blood from the heart to the legs and feet. Type 2 diabetes mellitus is the second most common risk factor for peripheral arterial disease.
Dessalew Abelneh Woleli, Gebiyaw Wudie Tsegaye, Taye Abuhay, Abyot Terefe Teshome, Gebrie Getu Alemu   +4 more
doaj   +1 more source

Underutilization of Evidence‐Based Smoking Cessation Support Strategies Despite High Smoking Addiction Burden in Peripheral Artery Disease Specialty Care: Insights from the International PORTRAIT Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Smoking is the most important risk factor for peripheral artery disease (PAD). Smoking cessation is key in PAD management. We aimed to examine smoking rates and smoking cessation interventions offered to patients with PAD consulting a vascular
Krishna K. Patel, Philip G. Jones, Edward F. Ellerbeck, Donna M. Buchanan, Paul S. Chan, Christina M. Pacheco, Gregory Moneta, John A. Spertus, Kim G. Smolderen   +8 more
doaj   +1 more source